Expression of estrogen receptor-alpha in cells of the osteoclastic lineage
Expression of estrogen receptor-alpha in cells of the osteoclastic lineage
复制标题
DOI:
10.1007/s004180050342
复制
发表时间:
1999-02-01
影响因子:
2.3
通讯作者:
Triffitt, JT
中科院分区:
文献类型:
--
作者:
Oreffo, ROC;Kusec, V;Triffitt, JT
Estrogen deficiency at the menopause is associated with an increased rate of bone loss and subsequent risk of skeletal fracture. Whilst cells of the osteoblastic lineage are known to express estrogen receptors, the presence of estrogen receptors in osteoclasts remains controversial. We have examined expression of the classic estrogen receptor, estrogen receptor-alpha (ER alpha), during osteoclast differentiation. In situ mRNA hybridisation with a digoxygenin-labelled riboprobe to ER alpha mRNA, together with immunocytochemical analysis using a human ER alpha-specific monoclonal antibody demonstrated similar findings and confirmed the expression of ER alpha in chondroblasts and osteoblasts from human fetal bone and mineralising human bone marrow cultures. ER alpha expression was detected in human bone marrow cultures treated with 1,25(OH)(2)D(3) and macrophage colony-stimulating factor and in macrophage cultures treated with 1,25(OH)(2)D(3). However, in an in vitro model of human osteoclast formation, no ER alpha expression was observed in the osteoclasts that developed, The human preosteoclast TCG 51 cell line showed strong expression of ER alpha in contrast to the low levels observed in the more mature bone resorptive TCG 23 cell line. No expression was detectable in osteoclasts cultured from giant cell tumour of bone (GCTB) tissue or in osteoclasts in Pagetic, GCTB, or hyperparathyroid bone tissues. In conclusion, preosteoclasts express detectable levels of ER alpha, but osteoclast maturation and bone resorption is associated with loss of ER alpha expression. This indicates that ER alpha expression and regulation may play a role in osteoclast formation.